Prelude Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Prelude Capital Management’s Portfolio XERS Stock Details XERS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$126K	Hold
2025 Q2	$72.4K	Buy
2020 Q4	–	Hold
2020 Q3	–	Hold
2019 Q3	–	Sell
2019 Q2	$9K	Buy